This study demonstrated that the antimicrobial protein Lcn2 protects against CPM-induced cytotoxicity and bacterial sepsis and extends survival in an experimental model of polymicrobial sepsis designed to reproduce the pathophysiologic sequence of events that occurs following cytoablative chemotherapy (Figure 3). The gene discussed is LCN2; the disease is Sepsis.